CytomX Therapeutics (CTMX) PT Lowered to $9 at Jefferies
Tweet
Share
E-mailGet Alerts CTMX Hot Sheet
Price: $1.60 --0%
Rating Summary:
7 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 1
Rating Summary:
7 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 1
Join SI Premium – FREE
Jefferies analyst Biren Amin lowered the price target on CytomX Therapeutics (NASDAQ: CTMX) to $9.00 (from $10.00) while maintaining a Hold rating.
You May Also Be Interested In
- RBC Capital Downgrades Range Resources (RRC) to Sector Perform
- KLA Corporation (KLAC) PT Raised to $700 at TD Cowen
- Stifel Upgrades LeMaitre Vascular (LMAT) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
